Cytrx reported $3.1M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Bioline Rx BLRX:US USD 8.13M 1.5M
Brainstorm Cell Therapeutics BCLI:US USD 8.95M 1.1M
Celldex Therapeutics CLDX:US USD 18.61M 2.32M
Curis CRIS:US USD 10.01M 3.73M
Cytrx CYTR:US USD 3.1M 633.56K
Glaxosmithkline GSK:US GBP 22.81B 1.86B
Karyopharm Therapeutics KPTI:US USD 72M 10.24M
Northwest Biotherapeutics NWBO:US USD 116.13M 17.97M
Novartis NVS:US USD 28.66B 496M
Roche Holding ROG:VX 27.24B 170M
Seattle Genetics SGEN:US USD 818.4M 92.41M
Takeda 4502:JP JPY 2.24T 154.91B